Patents by Inventor Diana Miao

Diana Miao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE
    Publication number: 20220389519
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Application
    Filed: May 27, 2022
    Publication date: December 8, 2022
    Inventors: Eliezer Van Allen, Diana Miao
  • PBRM1 biomarkers predictive of anti-immune checkpoint response
    Patent number: 11377696
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: July 5, 2022
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Eliezer Van Allen, Diana Miao, Toni K. Choueiri
  • Biomarkers predictive of anti-immune checkpoint response
    Patent number: 11377697
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: July 5, 2022
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Eliezer Van Allen, Diana Miao
  • PBRM1 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE
    Publication number: 20190338369
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Application
    Filed: January 3, 2018
    Publication date: November 7, 2019
    Inventors: Eliezer Van Allen, Diana Miao, Toni K. Choueiri
  • BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE
    Publication number: 20190338370
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Application
    Filed: January 9, 2018
    Publication date: November 7, 2019
    Inventors: Eliezer Van Allen, Diana Miao